PASCAL BIOSCIENCES ANNOUNCES PRIVATE PLACEMENT AND POTENTIAL TRANSACTION WITH SŌRSE TECHNOLOGY FOR CANNABINOID RESEARCH PROGRAMS
10 mars 2020 08h45 HE
|
Pascal Biosciences Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 10, 2020 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc....
Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia
29 oct. 2019 08h30 HE
|
Pascal Biosciences Inc.
VANCOUVER, British Columbia and SEATTLE and DAEJON, Korea, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal”) and Y-Biologics (together the “Companies”) today announced...
Pascal Biosciences Discovers Cannabinoids Activate the Major Histocompatibility Complex to Aid Cancer Treatment
23 sept. 2019 08h30 HE
|
Pascal Biosciences Inc.
VANCOUVER, British Columbia, and SEATTLE, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”) today revealed the mechanism whereby cannabinoids may...
Pascal Biosciences to Present at International Cannabinoid Derived Pharmaceuticals Summit
11 sept. 2019 08h30 HE
|
Pascal Biosciences Inc.
VANCOUVER, British Columbia and SEATTLE, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”). Pascal announces that Dr. Patrick Gray, CEO, will present...
Pascal Biosciences to Present at 2019 BIO International Convention
29 mai 2019 08h30 HE
|
Pascal Biosciences Inc.
Vancouver, BRITISH COLUMBIA and SEATTLE, May 29, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced...
Pascal Biosciences Announces Formation of Clinical Advisory Board
08 mai 2019 08h30 HE
|
Pascal Biosciences Inc.
VANCOUVER, British Columbia and SEATTLE, May 08, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced...
Pascal Biosciences Provides Corporate Update for First Quarter of 2019
23 avr. 2019 08h30 HE
|
Pascal Biosciences Inc.
VANCOUVER, British Columbia and SEATTLE, April 23, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today provided...
Pascal Biosciences names Carl Weissman acting President
01 avr. 2019 08h30 HE
|
Pascal Biosciences Inc.
VANCOUVER, BRITISH COLUMBIA, and SEATTLE, April 01, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today...
Pascal Biosciences Partners with Mitacs to Support Innovative Cancer Research at University of British Columbia
18 mars 2019 08h30 HE
|
Pascal Biosciences Inc.
VANCOUVER, British Columbia and SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced...
Pascal Biosciences Commences Cannabinoid Testing of Human Volunteers and Patients
24 janv. 2019 08h00 HE
|
Pascal Biosciences Inc.
VANCOUVER, British Columbia, and SEATTLE, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced...